Malignant Head and Neck Neoplasm clinical trials
135 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
- Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
- ATATcH Alternating Treatment Plans for Advanced Cancer
- Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
- Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
- Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
- Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction
- Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- Skin Color Matching in Head and Neck Reconstructive Surgery
- Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
- Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
- Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
- Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
- Jump: MR Simulation For Radiation Therapy Master Protocol
- Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
- Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
- A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- RAPA-201 Therapy of Solid Tumors
- Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
- Brodalumab in the Treatment of Immune-Related Adverse Events
- IDOV-Immune for Advanced Solid Tumors
- Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- Lead-212 PSV359 Therapy for Patients With Solid Tumors
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
- Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
- Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
- SMP-3124LP in Adults With Advanced Solid Tumors
- AMT-116 in Patients With Advanced Solid Tumors
- First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Study of SGN1 in Patients With Advanced Solid Tumor
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Apixaban or Enoxaparin After Head and Neck Cancer Surgery
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Malignant Head and Neck Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.